LOGIN  |  REGISTER
Chimerix
Recursion

DBV Technologies: Information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024

April 04, 2024 | Last Trade: US$10.83 0.16 -1.46

DBV Technologies - Information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024

(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)

Market : NYSE Euronext Paris
ISIN Code: FR 0010417345

 

Date

 
Total number of shares Total number of voting rights
03/31/2024

 
96,434,369

 
 

Total gross of voting rights: 96,434,369

 
 

Total net* of voting rights: 96,171,725

 

* Net total = total number of voting rights attached to shares – shares without voting rights

Stock Quote

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page